Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT05719701 · UNKNOWN
Trial details
- NCT number
- NCT05719701
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-29
- Primary completion
- 2025-07-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.